SBI-553 is primarily used in biochemical and pharmacological research as a selective modulator of specific cellular pathways. It has been investigated for its ability to influence protein-protein interactions involved in disease-related signaling mechanisms. Due to its targeted activity, SBI-553 serves as a valuable tool compound in studying oncogenic processes and identifying potential therapeutic interventions in cancer biology. Its application extends to in vitro assays and cell-based models where precise control over molecular targets is required. Ongoing research explores its potential in drug discovery programs focused on developing novel anti-cancer agents.